Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and nine months ended December 31 2025.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]